Ultrasound-on-Chip Licensing Market to Reach $200.5 Million by 2036

The global Ultrasound-on-Chip licensing market is forecasted to expand significantly, reaching USD 200.5 million by 2036 from an estimated USD 50.0 million in 2026. The market is experiencing a projected compound annual growth rate (CAGR) of 14.9%, driven by the increasing demand for compact ultrasound systems, AI-powered diagnostic tools, and handheld imaging devices. Licensing agreements between technology developers and medical device original equipment manufacturers (OEMs) are also fueling this growth.

The market is expected to generate an additional opportunity of USD 150.5 million between 2026 and 2036. Investments in AI-assisted diagnostics, semiconductor-based imaging technologies, and embedded ultrasound platforms are strengthening commercial prospects across the global healthcare sector. China is anticipated to be the fastest-growing country market, with a projected CAGR of 16.8% during the forecast period.

Butterfly Embedded is identified as the leading technology provider, holding a 61.0% market share in 2026. Its proprietary Ultrasound-on-Chip platform allows OEMs to integrate advanced imaging capabilities into medical and industrial devices without needing to develop proprietary transducer technologies. The medical application segment dominates the market, accounting for 72.0% of demand in 2026, due to the growing adoption of portable ultrasound systems in emergency medicine, cardiology, and primary healthcare.

Technology licensing agreements are enabling medical device manufacturers to commercialize advanced ultrasound systems more rapidly while reducing research and development costs. These partnerships increasingly involve semiconductor platforms, software development kits, and AI integration. Companies offering flexible licensing models and long-term engineering collaboration are expected to shape the future of portable medical imaging.